U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Obesity and Metabolism Research: Davis, CA
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        


                    Laboratories
                        Bennett Group
                                    Huang Group
                                    Keim Group
                                    Laugero Group
                                    Newman GroupSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Pacific West Area Davis, California Western Human Nutrition Research Center Obesity and Metabolism Research Research Publications at this Location





- ARS National Programs
- Search for a scientific manuscript
- Search for a research project
- ARS Software
- Programs and Projects
- Collaborations
- Subjects of Investigation
- Publications

Title:   Author  item
                                            Adams, Seanitem
                                            HOPPEL, CHARLES - CASE WESTERN RESERVE UNIVitem
                                            LOK, KERRY - UNIV. OF ALABAMAitem
                                            ZHAO, LING - UC DAVIS, NUTR. DEPT.item
                                            Wong, Scottitem
                                            MINKLER, PAUL - CASE WESTERN RESERVE UNIVitem
                                            Hwang, Danielitem
                                            Newman, Johnitem
                                            GARVEY, W. - UNIV. OF ALABAMA
  Submitted to: Journal of Nutrition
                                    Publication Type: Peer Reviewed Journal
                                    Publication Acceptance Date: 1/15/2009
                                    Publication  Date: 3/10/2009
                                    Citation: Adams, S.H., Hoppel, C.L., Lok, K.H., Zhao, L., Wong, S.W., Minkler, P.E., Hwang, D.H., Newman, J.W., Garvey, W.T. 2009. Plasma Acylcarnitine Profiles Suggest Incomplete Fatty Acid ß-Oxidation and Altered Tricarboxylic Cycle Activity in Type 2 Diabetic African-American Women. Journal of Nutrition, 139:1073-1081.Interpretive Summary: Inefficient muscle long-chain fatty acid (LCFA) combustion is associated with insulin resistance, but molecular links between mitochondrial fat catabolism and insulin action remain controversial. We hypothesized that plasma acylcarnitine profiling would identify distinct metabolite patterns reflective of muscle fat catabolism when comparing individuals bearing a missense G304A uncoupling protein 3 (UCP3 g/a) polymorphism to controls, since UCP3 is predominantly expressed in skeletal muscle and g/a individuals have reduced whole-body fat oxidation. Mass-spectroscopy analyses of 42 acylcarnitine moieties in plasma samples from overnight-fasted type 2 diabetics (n=44) and non-diabetics (n=12) with or without the UCP3 g/a polymorphism (n=28/genotype: 22 diabetic, 6 non-diabetic/genotype) were conducted. Contrary to our hypothesis, genotype had negligible impact on plasma metabolite patterns. However, a comparison of non-diabetics vs. type 2 diabetics revealed a striking increase in the concentrations of fatty acylcarnitines reflective of incomplete LCFA ß-oxidation in the latter (i.e., summed C10- to C14-carnitine concentrations were ~300% of controls, p=0.004). Across all volunteers (n=56), acetylcarnitine rose and propionylcarnitine decreased with increasing hemoglobin A1c (HbA1c; r = 0.544, P<0.0001 and r = -0.308, P<0.05, respectively) and with increasing total plasma acylcarnitine concentration.  In proof-of-concept studies, we made the novel observation that C12-C14 acylarnitines significantly stimulated NF'B activity (up to 200% of controls) in RAW264.7 cells. These results are consistent with the working hypothesis that inefficient tissue LCFA ß-oxidation, due in part to a relatively low tricarboxylic acid (TCA) cycle capacity, increases tissue accumulation of acetyl-CoA and generates chain-shortened acylcarnitine molecules that activate pro-inflammatory pathways implicated in insulin resistance.
                                Technical Abstract: Inefficient muscle long-chain fatty acid (LCFA) combustion is associated with insulin resistance, but molecular links between mitochondrial fat catabolism and insulin action remain controversial.  We hypothesized that plasma acylcarnitine profiling would identify distinct metabolite patterns reflective of muscle fat catabolism when comparing individuals bearing a missense G304A uncoupling protein 3 (UCP3 g/a) polymorphism to controls, since UCP3 is predominantly expressed in skeletal muscle and g/a individuals have reduced whole-body fat oxidation.  Mass-spectroscopy analyses of 42 acylcarnitine moieties in plasma samples from overnight-fasted type 2 diabetics (n=44) and non-diabetics (n=12) with or without the UCP3 g/a polymorphism (n=28/genotype:  22 diabetic, 6 non-diabetic/genotype) were conducted.  Contrary to our hypothesis, genotype had negligible impact on plasma metabolite patterns.  However, a comparison of non-diabetics vs.  type 2 diabetics revealed a striking increase in the concentrations of fatty acylcarnitines reflective of incomplete LCFA ß-oxidation in the latter (i.e., summed C10- to C14-carnitine concentrations were ~300% of controls, p=0.004).  Across all volunteers (n=56), acetylcarnitine rose and propionylcarnitine decreased with increasing hemoglobin A1c (HbA1c; r = 0.544, P<0.0001 and r = -0.308, P<0.05, respectively) and with increasing total plasma acylcarnitine concentration.  In proof-of-concept studies, we made the novel observation that C12-C14 acylarnitines significantly stimulated NF'B activity (up to 200% of controls) in RAW264.7 cells.  These results are consistent with the working hypothesis that inefficient tissue LCFA ß-oxidation, due in part to a relatively low tricarboxylic acid (TCA) cycle capacity, increases tissue accumulation of acetyl-CoA and generates chain-shortened acylcarnitine molecules that activate pro-inflammatory pathways implicated in insulin resistance.


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov